Pete Foley
Advertisement
Articles by Pete Foley
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
What Does a Positive Reading for Leronlimab Mean for How the Industry Thinks About Repurposing Old Biologics Into Oncology?
2
Why Leronlimab Isn’t Just Another Repurposed Drug: Q&A with Dr. Jay Lalezari
3
Lonza to Acquire Five U.S. CDMO Sites From Merck KGaA
4
How Tumors Change Over Time, and How This Impacts Treatment
5